Detalhe da pesquisa
1.
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Lancet Oncol
; 21(11): 1455-1464, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33152285
2.
Frequency and spectrum of PIK3CA somatic mutations in breast cancer.
Breast Cancer Res
; 22(1): 45, 2020 05 13.
Artigo
Inglês
| MEDLINE | ID: mdl-32404150
3.
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial.
Int J Cancer
; 147(1): 160-169, 2020 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31724170
4.
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study.
Br J Cancer
; 122(11): 1611-1617, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32231293
5.
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak.
Eur J Clin Invest
; 50(9): e13315, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32535890
6.
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies.
EBioMedicine
; 102: 105043, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38447275
7.
Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy.
Breast Cancer Res Treat
; 171(1): 245-246, 2018 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-29744675
8.
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial.
Tumori
; 109(1): 71-78, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34989265
9.
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives.
Crit Rev Oncol Hematol
; 181: 103900, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36565894
10.
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1.
J Natl Cancer Inst
; 115(3): 332-336, 2023 03 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36576009
11.
SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials.
Clin Cancer Res
; 29(24): 5217-5226, 2023 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37888299
12.
De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence.
Clin Breast Cancer
; 22(1): 78-87, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34750070
13.
Intrinsic subtypes and therapeutic decision-making in hormone receptor-positive/HER2-negative metastatic breast cancer with visceral crisis: A case report.
Front Oncol
; 12: 1009352, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36425558
14.
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer.
EBioMedicine
; 75: 103801, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34990895
15.
Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care Workers.
In Vivo
; 35(1): 635-639, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33402520
16.
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis.
Cancers (Basel)
; 13(6)2021 Mar 22.
Artigo
Inglês
| MEDLINE | ID: mdl-33810205
17.
Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy.
Clin Cancer Res
; 27(11): 3116-3125, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33632929
18.
Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy.
NPJ Breast Cancer
; 7(1): 8, 2021 Feb 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33536433
19.
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer.
NPJ Breast Cancer
; 7(1): 1, 2021 Jan 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33397968
20.
Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer.
Cancers (Basel)
; 12(8)2020 Aug 18.
Artigo
Inglês
| MEDLINE | ID: mdl-32824674